CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
Source: SeekingAlpha
2026-02-14 02:37:45 ET
CorMedix Inc. (CRMD) Analyst/Investor Day February 10, 2026 1:00 PM EST
Company Participants
Matt David - EVP & Chief Business Officer
Joseph Todisco - CEO & Chairman of the Board of Directors
Elizabeth Masson-Hurlburt - Executive VP, Chief Operating Officer & Chief Integration Officer
Peter Sullivan
Jared Crandon
...
Read the full article on Seeking Alpha
For further details see:
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc.
NASDAQ: CRMD
CRMD Trading
-2.55% G/L:
$7.08 Last:
553,740 Volume:
$7.20 Open:
CRMD Latest News
January 29, 2026 08:30:00 am
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
January 14, 2026 09:58:00 am
Lost Money on CorMedix Inc. (CRMD)? Contact Levi & Korsinsky About Fraud Investigation
January 09, 2026 08:30:00 am
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
CRMD Stock Data
$605,887,756
76,346,585
2.82%
76
N/A
Biotechnology & Life Sciences
Healthcare
US
Berkeley Heights
